Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses treatment options for end-stage kidney disease, also known as end-stage renal disease. The treatments include dialysis, transplantation, or medical management,…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, explains what to expect after a radical nephrectomy. The procedure can be done minimally invasively, either laparoscopically or robotically,…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
April W. Armstrong, MD, MPH, of @KeckMedUSC, and Erin E. Boh, MD, PhD, of @TulaneMedicine, discuss the use of IL-23 and IL-17 inhibitors in #psoriaticdisease.
This video from the National Kidney Foundation highlights the importance of maintaining the right amount of potassium in the body, as it is vital for the proper functioning…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses considerations for partial or radical nephrectomy. Chronic kidney disease can lead to a loss of kidney function, which…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses what to expect after a robotic-assisted partial nephrectomy. The procedure is performed using a da Vinci robot to…
Polycystic kidney disease is a hereditary condition where multiple cysts develop within the renal tubules of the kidney, impairing their function. As the cysts grow, they compress nearby…
David L. Green, MD, PhD, MBA, founder and CEO of R3 Stem Cell International, discusses stem cell therapy for kidney failure in South Africa. He explains the function…
